The National Institutes of Health (NIH) is using a women’s health grant to provide funding for a study that is actively recruiting 18-year-olds to experiment with the “unknown” cardiovascular side effects of removing young males’ testicles.
According to Fox News, the study is seeking 18-year-old men who have been diagnosed with gender dysphoria, the mental illness which leads individuals to believe that they are somehow the “wrong” gender.” The experiment will involve 30 young men who are interested in undergoing the orchiectomy procedure, also known as “surgical castration.”
The leader of the study is Sean Iwamoto, an Assistant Professor of Medicine at the University of Colorado’s Anschutz Medical Campus. But despite being placed in charge, Iwamoto has not yet made any concrete predictions as to what he expects to learn from the study. Even the project’s preliminary abstract admits that there has been a lack of research when it comes to “side effects” of the orchiectomy.
But Iwamoto’s biography page on the university’s website shows his biases in favor of the procedure, which he declares, with no evidence, to be “life-saving” and capable of providing “maximal health benefits.”
“Better understanding acute and chronic effects of… gender-affirming surgery… will increase our confidence that these life-saving treatments provide maximal physical and mental health benefits and minimal risks, particularly related to cardiovascular disease,” Iwamoto says on his own page.
The study’s statements reflect Iwamoto’s predetermined stances, claiming that “Trans women appear to be at greater risk for cardiovascular disease (CVD) and blood clots compared to non-trans adults. The effect of orchiectomy on CVD risk among trans women is unknown, but orchiectomy may change blood vessel function and metabolic health.”
Iwamoto has also said that his project will collaborate with international organizations as well, saying that “my collaborations with national and international leaders continue to inspire me to focus on this niche research area with broad implications for health in adults across age, sex, and gender identity spectra.”
Aside from being used to mutilate a man’s genitals as part of the “sex change” surgeries demanded by the far-left transgender lobby, an orchiectomy can also be used to manage testicular and prostate cancer. However, a study done in 2017 acknowledged that the side effects of orchiectomies on cancer patients can include “higher rates of [cardiovascular] ischemic events in older patients.”
“Cardiovascular events or their minor syndromes, as various forms of ischemia, are considered medical emergencies,” the study explained, as published in Cardiovascular Diabetology.